News Detail
California, 26 Nov 2024: The US Food and Drug Administration (FDA) has approved View Details
Source : Pharmaceutical Technology
US Food and Drug Administration (FDA)
oral transthyretin (TTR) stabiliser
Attruby (acoramidis)
BridgeBio Pharma
Related News
- Not to rely on unproven remedies, no evidence to support Sidhu's claims: Oncologists (26-11-2024)
- Free medicine scheme: 795 Samples of cancer, blood and heart related medicines failed, complaint in only 12% cases (26-11-2024)
- Two smugglers arrested with 5070 narcotic tablets (26-11-2024)
- RG Kar Hospital case: Expired medicines sold in new packaging, CBI found evidence (26-11-2024)
- Experts urge mandatory NAT testing for blood transfusion safety in India (26-11-2024)
- NGH police seizes 2500 Phensedyl bottles, 3 held (26-11-2024)
- Himachal: 20 pharma industries samples failed repeatedly, now they will be blacklisted: Dr. Shandil (26-11-2024)
- DCA Telangana seizes overpriced 'Itwage-200 Capsules' (25-11-2024)
- BIS to prioritise development of standards for 214 critical medical devices (25-11-2024)
- Liver infection Patient in JLN given expired medicine (25-11-2024)